Entresto heart failure drug. Packaging for the combination drug sacubitril and valsarta, sold here under the brand name Entrasto, and developed and ma

---

Entresto heart failure drug. Packaging for the combination drug sacubitril and valsarta, sold here under the brand name Entrasto, and developed and marketed by the Novartis pharmaceutical company. The drug sacubitril acts to inhibit the neprilysin enzyme, while the drug valsartan is an angiotensin receptor blocker (ARB). This combination drug was approved for use in 2015.

---

Size: 5144px × 3405px
Photo credit: © DR P. MARAZZI/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: -, arb, background, cardiac, cardiovascular, combination, cut, cut-, cut-outs, cutout, cutouts, drug, entresto, failure, film-coated, heart, inhibitor, label, labeled, labelled, labels, life, medical, medicine, neprilysin, novartis, oral, outs, packaging, packet, pharmaceutical, pharmaceutics, pharmacological, pharmacology, sacubitril, shot, studio, text, valsarta, white